Among 52 patients with evaluable tumor biopsy samples, 84.6% harbored PD-L1− tumors per TPS (n/N = 44/52), and 50.0% of those patients were also PD-L1− per CPS (n/N = 22/44). The gene discussed is CD274; the disease is neoplasm.